Loading Complete
Roger S Keresztes, MD
Hematology Oncology
Accepting New Patients
Video Visit
Need help scheduling? Call 631-638-1000
Highlights
Languages
- Hungarian
- English
Gender
MaleAbout Roger S Keresztes
Academic Title
Clinical Associate Professor in Medicine
Publications
- Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer.
Edelman MJ | Tan MT | Fidler MJ | Sanborn RE | Otterson G | Sequist LV | Evans TL | Schneider BJ | Keresztes R | Rogers JS | de Mayolo JA | Feliciano J | Yang Y | Medeiros M | Zaknoen SL
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2015 Jan 10 - Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach.
Ocean AJ | Christos P | Sparano JA | Shah MA | Yantiss RK | Cheng J | Lin J | Papetti M | Matulich D | Schnoll-Sussman F | Besanceney-Webler C | Xiang J | Ward M | Dilts KT | Keresztes R | Holloway S | Chen EX | Wright JJ | Lane ME
Investigational new drugs
2014 Jun - Antiangiogenic agents for the treatment of nonsmall cell lung cancer: characterizing the molecular basis for serious adverse events.
Wu S | Keresztes RS
Cancer investigation
2011 Aug - Preoperative taxane-based chemotherapy and celecoxib for carcinoma of the esophagus and gastroesophageal junction: results of a phase 2 trial.
Altorki NK | Christos P | Port JL | Lee PC | Mirza F | Spinelli C | Keresztes R | Beneck D | Paul S | Stiles BM | Zhang Y | Schrump DS
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
2011 Jun - Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis.
Nalluri SR | Chu D | Keresztes R | Zhu X | Wu S
JAMA : the journal of the American Medical Association
2008 Nov 19 - Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer.
Lilenbaum R | Socinski MA | Altorki NK | Hart LL | Keresztes RS | Hariharan S | Morrison ME | Fayyad R | Bonomi P
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2006 Oct 20 - Surgical resection for residual N2 disease after induction chemotherapy.
Port JL | Korst RJ | Lee PC | Levin MA | Becker DE | Keresztes R | Altorki NK
The Annals of thoracic surgery
2005 May - Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.
Winer EP | Berry DA | Woolf S | Duggan D | Kornblith A | Harris LN | Michaelson RA | Kirshner JA | Fleming GF | Perry MC | Graham ML | Sharp SA | Keresztes R | Henderson IC | Hudis C | Muss H | Norton L
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2004 Jun 1 - Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer.
Port JL | Kent MS | Korst RJ | Keresztes R | Levin MA | Altorki NK
The Annals of thoracic surgery
2004 Jan - Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer.
Altorki NK | Keresztes RS | Port JL | Libby DM | Korst RJ | Flieder DB | Ferrara CA | Yankelevitz DF | Subbaramaiah K | Pasmantier MW | Dannenberg AJ
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2003 Jul 15 - A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
Sandler RS | Halabi S | Baron JA | Budinger S | Paskett E | Keresztes R | Petrelli N | Pipas JM | Karp DD | Loprinzi CL | Steinbach G | Schilsky R
The New England journal of medicine
2003 Mar 6 - Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: results of a phase II trial.
Keresztes RS | Port JL | Pasmantier MW | Korst RJ | Altorki NK
The Journal of thoracic and cardiovascular surgery
2003 Nov - Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer.
Gure AO | Stockert E | Scanlan MJ | Keresztes RS | Jager D | Altorki NK | Old LJ | Chen YT
Proceedings of the National Academy of Sciences of the United States of America
2000 Apr 11
Locations
- Stony Brook Cancer Center - Medical Oncology
- Lauterbur Drive, Stony Brook, NY 11794
- Get Directions
- phone: 631-638-1000
- fax: 631-638-0915
- The Phillips Family Cancer Center - Medical Oncology Provider
- 740 County Road 39A, Southampton, NY 11968
- Get Directions
- phone: 631-638-7702
- fax: 631-638-7327
Expertise
Education
- Fellowship: New York-Presbyterian University Hospital of Columbia and Cornell, IM-Hematology/Oncol, 1993
- Residency: New York-Presbyterian University Hospital of Columbia and Cornell, Internal Medicine, 1990
- Medical School: University of Medicine and Dentistry of New Jersey, 1987
Insurance
Please contact the doctor's office directly to confirm acceptance of insurance.
Search plans
- (Anthem) EMP HEALTH CHOICE HMO
- (Anthem) EMP HEALTH CHOICE MEDICAID
- (Anthem) EMP HEALTH CHOICE PPO
- (Anthem) EMP HEALTH CHOICE SR
- (Emblem) HIP
- AETNA
- Affinity
- Beech Street
- Beech Street/Multiplan/PHCS
- Centerlight (CCM)
- CIGNA HMO
- CIGNA PPO
- Fidelis
- GHI / MEDICARE PLUS
- GHI CBP
- GHI HMO
- Great West
- Health Smart WTC
- HEALTHFIRST
- Humana Military
- MAGNACARE
- MET EMPIRE
- OXFORD
- Partners Health Plan
- Sedgwick
- UNITED HEALTH CARE / CHP / MEDICAID
- UNITED HEALTHCARE
- Workers Compensation
